Finance

Lists
ALIVUS:NSE
Alivus Life Sciences Ltd
₹1,366.60
-0.58%
(-8.00) 1D
Aug 14, 10:47:11 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALIVUS...
Open
₹1,374.60
High
₹1,387.40
Low
₹1,361.50
Mkt. cap
167.58B
Avg. vol.
0.00
Volume
9.33K
Dividend
0.37%
Quarterly dividend
₹1.25
Ex-dividend date
Sep 1, 2025
P/E ratio
27.87
52-wk high
₹1,418.00
52-wk low
₹819.00
EPS
₹49.03
No. of employees
2K
Open
₹1,374.60
High
₹1,387.40
Low
₹1,361.50
Mkt. cap
167.58B
Avg. vol.
0.00
Volume
9.33K
Dividend
0.37%
Quarterly dividend
₹1.25
Ex-dividend date
Sep 1, 2025
P/E ratio
27.87
52-wk high
₹1,418.00
52-wk low
₹819.00
EPS
₹49.03
No. of employees
2K
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2.2K
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com
Last report
Jul 30, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹13.01 / ₹12.10
+7.52%beat
Revenue / Est. (INR)
6.40B / 6.68B
-4.06%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.88B
6.73B
6.89B
6.40B
Cost of goods sold
2.49B
2.76B
2.71B
2.55B
Cost of revenue
2.49B
2.76B
2.71B
2.55B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
664.00M
663.70M
781.22M
682.45M
Operating expense
1.78B
1.85B
2.24B
1.94B
Total operating expenses
4.27B
4.61B
4.95B
4.49B
Operating income
1.61B
2.12B
1.94B
1.91B
Other non operating income
147.20M
139.28M
227.78M
224.01M
EBT including unusual items
1.74B
1.98B
2.16B
2.12B
EBT excluding unusual items
1.74B
2.24B
2.16B
2.12B
Income tax expense
441.11M
481.31M
531.38M
521.47M
Effective tax rate
25.33%
24.26%
24.62%
24.57%
Other operating expenses
934.91M
988.28M
1.26B
1.05B
Net income
1.30B
1.50B
1.63B
1.60B
Net profit margin
22.11%
22.33%
23.60%
25.00%
Earnings per share
10.58
13.80
13.22
13.01
Interest and investment income
-
-
-
-
Interest expense
-13.18M
-14.94M
-13.09M
-13.07M
Net interest expenses
-13.18M
-14.94M
-13.09M
-13.07M
Depreciation and amortization charges
184.35M
196.58M
202.00M
205.85M
EBITDA
1.78B
2.25B
2.13B
2.10B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps